J. Guertin, J. LeLorier, M. Durand, R. Gow, A. Holbrook, and M. Levine, “IMPACT OF A RESTRICTIVE DRUG ACCESS PROGRAM ON THE RISK OF CARDIOVASCULAR ENCOUNTERS IN CHILDREN EXPOSED TO ADHD MEDICATIONS”, J Popl Ther Clin Pharmacol, vol. 21, no. 3, Nov. 2018.